nodes	percent_of_prediction	percent_of_DWPC	metapath
Levonorgestrel—Polymenorrhoea—Octreotide—thymus cancer	0.112	0.128	CcSEcCtD
Levonorgestrel—Appendicitis—Octreotide—thymus cancer	0.0521	0.0598	CcSEcCtD
Levonorgestrel—Oligomenorrhoea—Octreotide—thymus cancer	0.0521	0.0598	CcSEcCtD
Levonorgestrel—Otitis—Octreotide—thymus cancer	0.0465	0.0533	CcSEcCtD
Levonorgestrel—Breast neoplasm—Octreotide—thymus cancer	0.0267	0.0306	CcSEcCtD
Levonorgestrel—Varicose vein—Octreotide—thymus cancer	0.0217	0.0248	CcSEcCtD
Levonorgestrel—Hypochromic anaemia—Octreotide—thymus cancer	0.0208	0.0239	CcSEcCtD
Levonorgestrel—Ear infection—Octreotide—thymus cancer	0.019	0.0218	CcSEcCtD
Levonorgestrel—Abdominal bloating—Octreotide—thymus cancer	0.0169	0.0194	CcSEcCtD
Levonorgestrel—Pregnancy—Octreotide—thymus cancer	0.0142	0.0163	CcSEcCtD
Levonorgestrel—Haemorrhoids—Octreotide—thymus cancer	0.0137	0.0157	CcSEcCtD
Levonorgestrel—Haematoma—Octreotide—thymus cancer	0.0128	0.0147	CcSEcCtD
Levonorgestrel—Galactorrhoea—Octreotide—thymus cancer	0.0124	0.0143	CcSEcCtD
Levonorgestrel—Redness—Octreotide—thymus cancer	0.0119	0.0137	CcSEcCtD
Levonorgestrel—Seborrhoeic dermatitis—Octreotide—thymus cancer	0.0118	0.0136	CcSEcCtD
Levonorgestrel—Menstrual disorder—Octreotide—thymus cancer	0.0118	0.0136	CcSEcCtD
Levonorgestrel—Influenza-like symptoms—Octreotide—thymus cancer	0.0113	0.013	CcSEcCtD
Levonorgestrel—Metrorrhagia—Octreotide—thymus cancer	0.0113	0.013	CcSEcCtD
Levonorgestrel—Otitis media—Octreotide—thymus cancer	0.0104	0.0119	CcSEcCtD
Levonorgestrel—Numbness—Octreotide—thymus cancer	0.00973	0.0112	CcSEcCtD
Levonorgestrel—Endocrine disorder—Octreotide—thymus cancer	0.00973	0.0112	CcSEcCtD
Levonorgestrel—Acne—Octreotide—thymus cancer	0.00959	0.011	CcSEcCtD
Levonorgestrel—Sensory loss—Octreotide—thymus cancer	0.00931	0.0107	CcSEcCtD
Levonorgestrel—Contusion—Octreotide—thymus cancer	0.00924	0.0106	CcSEcCtD
Levonorgestrel—Breast pain—Octreotide—thymus cancer	0.00924	0.0106	CcSEcCtD
Levonorgestrel—Amenorrhoea—Octreotide—thymus cancer	0.00918	0.0105	CcSEcCtD
Levonorgestrel—SHBG—neck—thymus cancer	0.00885	0.069	CbGeAlD
Levonorgestrel—Herpes simplex—Octreotide—thymus cancer	0.00875	0.01	CcSEcCtD
Levonorgestrel—Muscle twitching—Octreotide—thymus cancer	0.00821	0.00942	CcSEcCtD
Levonorgestrel—Cystitis noninfective—Octreotide—thymus cancer	0.00788	0.00904	CcSEcCtD
Levonorgestrel—Influenza like illness—Octreotide—thymus cancer	0.00783	0.00898	CcSEcCtD
Levonorgestrel—Cystitis—Octreotide—thymus cancer	0.00779	0.00893	CcSEcCtD
Levonorgestrel—Candida infection—Octreotide—thymus cancer	0.0077	0.00883	CcSEcCtD
Levonorgestrel—Vaginal infection—Octreotide—thymus cancer	0.00761	0.00873	CcSEcCtD
Levonorgestrel—Cramps of lower extremities—Octreotide—thymus cancer	0.00741	0.0085	CcSEcCtD
Levonorgestrel—Bladder pain—Octreotide—thymus cancer	0.00729	0.00836	CcSEcCtD
Levonorgestrel—SHBG—hematopoietic system—thymus cancer	0.00659	0.0514	CbGeAlD
Levonorgestrel—ESR1—neck—thymus cancer	0.00623	0.0486	CbGeAlD
Levonorgestrel—PGR—hematopoietic system—thymus cancer	0.00593	0.0463	CbGeAlD
Levonorgestrel—Pain in extremity—Octreotide—thymus cancer	0.00585	0.00672	CcSEcCtD
Levonorgestrel—PGR—epithelium—thymus cancer	0.00542	0.0423	CbGeAlD
Levonorgestrel—Dry skin—Octreotide—thymus cancer	0.00537	0.00616	CcSEcCtD
Levonorgestrel—CYP19A1—hematopoietic system—thymus cancer	0.00534	0.0417	CbGeAlD
Levonorgestrel—Abdominal distension—Octreotide—thymus cancer	0.00509	0.00584	CcSEcCtD
Levonorgestrel—Influenza—Octreotide—thymus cancer	0.00506	0.0058	CcSEcCtD
Levonorgestrel—Asthma—Octreotide—thymus cancer	0.00506	0.0058	CcSEcCtD
Levonorgestrel—Sweating increased—Octreotide—thymus cancer	0.00493	0.00565	CcSEcCtD
Levonorgestrel—SHBG—pituitary gland—thymus cancer	0.00489	0.0381	CbGeAlD
Levonorgestrel—Bronchitis—Octreotide—thymus cancer	0.00487	0.00558	CcSEcCtD
Levonorgestrel—Dysuria—Octreotide—thymus cancer	0.00473	0.00543	CcSEcCtD
Levonorgestrel—AR—hematopoietic system—thymus cancer	0.00473	0.0369	CbGeAlD
Levonorgestrel—Upper respiratory tract infection—Octreotide—thymus cancer	0.0047	0.00539	CcSEcCtD
Levonorgestrel—Pollakiuria—Octreotide—thymus cancer	0.00467	0.00536	CcSEcCtD
Levonorgestrel—ESR1—hematopoietic system—thymus cancer	0.00464	0.0362	CbGeAlD
Levonorgestrel—Weight increased—Octreotide—thymus cancer	0.00461	0.00528	CcSEcCtD
Levonorgestrel—Weight decreased—Octreotide—thymus cancer	0.00458	0.00525	CcSEcCtD
Levonorgestrel—Pneumonia—Octreotide—thymus cancer	0.00454	0.00521	CcSEcCtD
Levonorgestrel—Depression—Octreotide—thymus cancer	0.0045	0.00516	CcSEcCtD
Levonorgestrel—PGR—pituitary gland—thymus cancer	0.0044	0.0343	CbGeAlD
Levonorgestrel—Urinary tract infection—Octreotide—thymus cancer	0.00439	0.00503	CcSEcCtD
Levonorgestrel—AR—epithelium—thymus cancer	0.00432	0.0337	CbGeAlD
Levonorgestrel—ESR1—epithelium—thymus cancer	0.00424	0.0331	CbGeAlD
Levonorgestrel—Sinusitis—Octreotide—thymus cancer	0.00423	0.00486	CcSEcCtD
Levonorgestrel—SHBG—bone marrow—thymus cancer	0.00422	0.0329	CbGeAlD
Levonorgestrel—SHBG—thyroid gland—thymus cancer	0.00421	0.0329	CbGeAlD
Levonorgestrel—PGR—lymphoid tissue—thymus cancer	0.00418	0.0326	CbGeAlD
Levonorgestrel—Rhinitis—Octreotide—thymus cancer	0.00406	0.00466	CcSEcCtD
Levonorgestrel—Hypoaesthesia—Octreotide—thymus cancer	0.00403	0.00462	CcSEcCtD
Levonorgestrel—Pharyngitis—Octreotide—thymus cancer	0.00402	0.00461	CcSEcCtD
Levonorgestrel—Visual impairment—Octreotide—thymus cancer	0.0039	0.00448	CcSEcCtD
Levonorgestrel—PGR—thyroid gland—thymus cancer	0.00379	0.0296	CbGeAlD
Levonorgestrel—Cardiac disorder—Octreotide—thymus cancer	0.00376	0.00431	CcSEcCtD
Levonorgestrel—Immune system disorder—Octreotide—thymus cancer	0.00366	0.0042	CcSEcCtD
Levonorgestrel—Arrhythmia—Octreotide—thymus cancer	0.00362	0.00415	CcSEcCtD
Levonorgestrel—AR—cardiac atrium—thymus cancer	0.00359	0.028	CbGeAlD
Levonorgestrel—Alopecia—Octreotide—thymus cancer	0.00358	0.00411	CcSEcCtD
Levonorgestrel—Mental disorder—Octreotide—thymus cancer	0.00355	0.00407	CcSEcCtD
Levonorgestrel—Malnutrition—Octreotide—thymus cancer	0.00353	0.00404	CcSEcCtD
Levonorgestrel—Erythema—Octreotide—thymus cancer	0.00353	0.00404	CcSEcCtD
Levonorgestrel—AR—pituitary gland—thymus cancer	0.00351	0.0274	CbGeAlD
Levonorgestrel—Flatulence—Octreotide—thymus cancer	0.00347	0.00399	CcSEcCtD
Levonorgestrel—Tension—Octreotide—thymus cancer	0.00346	0.00397	CcSEcCtD
Levonorgestrel—PGR—lung—thymus cancer	0.00345	0.0269	CbGeAlD
Levonorgestrel—ESR1—pituitary gland—thymus cancer	0.00344	0.0269	CbGeAlD
Levonorgestrel—Nervousness—Octreotide—thymus cancer	0.00342	0.00393	CcSEcCtD
Levonorgestrel—CYP19A1—thyroid gland—thymus cancer	0.00341	0.0266	CbGeAlD
Levonorgestrel—Back pain—Octreotide—thymus cancer	0.00341	0.00391	CcSEcCtD
Levonorgestrel—Muscle spasms—Octreotide—thymus cancer	0.00339	0.00389	CcSEcCtD
Levonorgestrel—AR—lymphoid tissue—thymus cancer	0.00333	0.026	CbGeAlD
Levonorgestrel—ESR1—lymphoid tissue—thymus cancer	0.00327	0.0255	CbGeAlD
Levonorgestrel—Anaemia—Octreotide—thymus cancer	0.00326	0.00374	CcSEcCtD
Levonorgestrel—Vertigo—Octreotide—thymus cancer	0.00317	0.00363	CcSEcCtD
Levonorgestrel—Syncope—Octreotide—thymus cancer	0.00316	0.00363	CcSEcCtD
Levonorgestrel—Palpitations—Octreotide—thymus cancer	0.00312	0.00357	CcSEcCtD
Levonorgestrel—Loss of consciousness—Octreotide—thymus cancer	0.0031	0.00355	CcSEcCtD
Levonorgestrel—Cough—Octreotide—thymus cancer	0.00308	0.00353	CcSEcCtD
Levonorgestrel—Hypertension—Octreotide—thymus cancer	0.00304	0.00349	CcSEcCtD
Levonorgestrel—AR—thyroid gland—thymus cancer	0.00302	0.0236	CbGeAlD
Levonorgestrel—Chest pain—Octreotide—thymus cancer	0.003	0.00344	CcSEcCtD
Levonorgestrel—Myalgia—Octreotide—thymus cancer	0.003	0.00344	CcSEcCtD
Levonorgestrel—Anxiety—Octreotide—thymus cancer	0.00299	0.00343	CcSEcCtD
Levonorgestrel—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00298	0.00342	CcSEcCtD
Levonorgestrel—ESR1—thyroid gland—thymus cancer	0.00297	0.0231	CbGeAlD
Levonorgestrel—Discomfort—Octreotide—thymus cancer	0.00297	0.0034	CcSEcCtD
Levonorgestrel—Oedema—Octreotide—thymus cancer	0.00288	0.0033	CcSEcCtD
Levonorgestrel—Infection—Octreotide—thymus cancer	0.00286	0.00328	CcSEcCtD
Levonorgestrel—Shock—Octreotide—thymus cancer	0.00283	0.00325	CcSEcCtD
Levonorgestrel—Nervous system disorder—Octreotide—thymus cancer	0.00282	0.00324	CcSEcCtD
Levonorgestrel—Skin disorder—Octreotide—thymus cancer	0.0028	0.00321	CcSEcCtD
Levonorgestrel—Hyperhidrosis—Octreotide—thymus cancer	0.00278	0.00319	CcSEcCtD
Levonorgestrel—AR—lung—thymus cancer	0.00275	0.0214	CbGeAlD
Levonorgestrel—Anorexia—Octreotide—thymus cancer	0.00274	0.00315	CcSEcCtD
Levonorgestrel—ESR1—lung—thymus cancer	0.0027	0.021	CbGeAlD
Levonorgestrel—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00262	0.00301	CcSEcCtD
Levonorgestrel—Insomnia—Octreotide—thymus cancer	0.0026	0.00299	CcSEcCtD
Levonorgestrel—CYP3A4—hematopoietic system—thymus cancer	0.00259	0.0202	CbGeAlD
Levonorgestrel—Dyspnoea—Octreotide—thymus cancer	0.00257	0.00294	CcSEcCtD
Levonorgestrel—Somnolence—Octreotide—thymus cancer	0.00256	0.00293	CcSEcCtD
Levonorgestrel—Dyspepsia—Octreotide—thymus cancer	0.00253	0.00291	CcSEcCtD
Levonorgestrel—Decreased appetite—Octreotide—thymus cancer	0.0025	0.00287	CcSEcCtD
Levonorgestrel—Gastrointestinal disorder—Octreotide—thymus cancer	0.00248	0.00285	CcSEcCtD
Levonorgestrel—Fatigue—Octreotide—thymus cancer	0.00248	0.00285	CcSEcCtD
Levonorgestrel—Constipation—Octreotide—thymus cancer	0.00246	0.00282	CcSEcCtD
Levonorgestrel—Pain—Octreotide—thymus cancer	0.00246	0.00282	CcSEcCtD
Levonorgestrel—PGR—lymph node—thymus cancer	0.00236	0.0184	CbGeAlD
Levonorgestrel—Gastrointestinal pain—Octreotide—thymus cancer	0.00235	0.0027	CcSEcCtD
Levonorgestrel—Urticaria—Octreotide—thymus cancer	0.00229	0.00262	CcSEcCtD
Levonorgestrel—Abdominal pain—Octreotide—thymus cancer	0.00227	0.00261	CcSEcCtD
Levonorgestrel—Body temperature increased—Octreotide—thymus cancer	0.00227	0.00261	CcSEcCtD
Levonorgestrel—CYP19A1—lymph node—thymus cancer	0.00212	0.0165	CbGeAlD
Levonorgestrel—Hypersensitivity—Octreotide—thymus cancer	0.00212	0.00243	CcSEcCtD
Levonorgestrel—Asthenia—Octreotide—thymus cancer	0.00206	0.00237	CcSEcCtD
Levonorgestrel—Pruritus—Octreotide—thymus cancer	0.00204	0.00234	CcSEcCtD
Levonorgestrel—Diarrhoea—Octreotide—thymus cancer	0.00197	0.00226	CcSEcCtD
Levonorgestrel—Dizziness—Octreotide—thymus cancer	0.0019	0.00218	CcSEcCtD
Levonorgestrel—AR—lymph node—thymus cancer	0.00188	0.0146	CbGeAlD
Levonorgestrel—ESR1—lymph node—thymus cancer	0.00184	0.0144	CbGeAlD
Levonorgestrel—Vomiting—Octreotide—thymus cancer	0.00183	0.0021	CcSEcCtD
Levonorgestrel—Rash—Octreotide—thymus cancer	0.00181	0.00208	CcSEcCtD
Levonorgestrel—Dermatitis—Octreotide—thymus cancer	0.00181	0.00208	CcSEcCtD
Levonorgestrel—Headache—Octreotide—thymus cancer	0.0018	0.00207	CcSEcCtD
Levonorgestrel—Nausea—Octreotide—thymus cancer	0.00171	0.00196	CcSEcCtD
